Back
  • There are no suggestions because the search field is empty.
Aiforia® Prostate Cancer Suite

AI for prostate cancer diagnostics

Elevate your pathology lab with Aiforia® Prostate Cancer Suite – enhancing precision, speed, and diagnostic confidence with cutting-edge AI technology. 

Aiforia® Prostate Cancer Suite consists of AI models with an optimized interactive user interface that supports pathologists in Gleason grade grouping and identifying adverse histopathological features.

Only certain Aiforia® Clinical AI models and the Aiforia® Clinical Suite Viewer are CE-IVD marked for diagnostic use in EU and EEA countries; see details under each AI model.

Contact us
gleason grading of prostate cancer
Aiforia Prostate Cancer Suite_key features image

Enhance your pathology workflow with Aiforia

Aiforia® Prostate Cancer Suite offers a fully digital cockpit for prostate cancer diagnostics, giving the pathologist complete control of the results. 

  • AI assistance for first-read primary diagnostics

  • Automated suggestions for Gleason scoring, measurements, and presence of adverse findings

  • Comprehensive case-level review and reporting

  • Time and cost savings by automated reporting and worklist prioritization

Prostate Cancer Suite: AI models

Aiforia® Prostate Cancer Gleason Grade Groups
Aiforia® Prostate Cancer PNI
Aiforia® Prostate Cancer G4 Cribriform
Aiforia® Prostate Cancer HG-PIN
Prostate_20x_AImasks_cropped

Automatically identifies adenocarcinoma, streamlines the Gleason grading process, and directly addresses interobserver variability and subtle pattern detection challenges commonly faced by pathologists.

Clinical performance highlights
  • Exceptional diagnostic accuracy with excellent correlation to expert grading
  • Improved reproducibility and reduced interobserver variability
  • Significantly faster Gleason scoring, saving up to 34% of analysis time


CE-IVD marked for diagnostic use in EU and EEA countries, and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

PNI 40x all masks-1

Efficiently detects subtle perineural invasion (PNI) features, addressing the common diagnostic challenge of accurately and consistently identifying tumor involvement around nerves.

Clinical performance highlights
  • High diagnostic confidence with excellent correlation to visual assessments
  • Improved reproducibility, ensuring reliable identification of subtle PNI
  • Enhanced workflow efficiency with scoring times reduced by up to 29%


CE-IVD marked for diagnostic use in EU and EEA countries (IVDR) and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

G4 crib 20x adv mask only-1

Automatically detects Gleason Grade 4 Cribriform patterns in prostate biopsy whole slide images (WSI), addressing pathologists' challenges with subjective, time-consuming visual assessments, with the aim to reduce diagnostic variability and enhance workflow efficiency.

Clinical performance highlights
  • Excellent diagnostic reliability, consistently aligning with expert visual assessments.
  • Improved reproducibility and reduced diagnostic variability.
  • Significantly reduced analysis time, improving workflow by up to 54%.


CE-IVD marked for diagnostic use in EU and EEA countries (IVDR) and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

HGPIN 40x adv mask only-1

Supports the detection of high-grade prostatic intraepithelial neoplasia (high-grade PIN) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer HG-PIN is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Prostate Cancer Suite: AI models

Aiforia® Prostate Cancer Gleason Grade Groups

Prostate_20x_AImasks_cropped

Automatically identifies adenocarcinoma, streamlines the Gleason grading process, and directly addresses interobserver variability and subtle pattern detection challenges commonly faced by pathologists.

Clinical performance highlights
  • Exceptional diagnostic accuracy with excellent correlation to expert grading
  • Improved reproducibility and reduced interobserver variability
  • Significantly faster Gleason scoring, saving up to 34% of analysis time


CE-IVD marked for diagnostic use in EU and EEA countries, and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

Aiforia® Prostate Cancer PNI

PNI 40x all masks-1

Efficiently detects subtle perineural invasion (PNI) features, addressing the common diagnostic challenge of accurately and consistently identifying tumor involvement around nerves.

Clinical performance highlights
  • High diagnostic confidence with excellent correlation to visual assessments
  • Improved reproducibility, ensuring reliable identification of subtle PNI
  • Enhanced workflow efficiency with scoring times reduced by up to 29%


CE-IVD marked for diagnostic use in EU and EEA countries (IVDR) and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

Aiforia® Prostate Cancer G4 Cribriform

G4 crib 20x adv mask only-1

Automatically detects Gleason Grade 4 Cribriform patterns in prostate biopsy whole slide images (WSI), addressing pathologists' challenges with subjective, time-consuming visual assessments, with the aim to reduce diagnostic variability and enhance workflow efficiency.

Clinical performance highlights
  • Excellent diagnostic reliability, consistently aligning with expert visual assessments.
  • Improved reproducibility and reduced diagnostic variability.
  • Significantly reduced analysis time, improving workflow by up to 54%.


CE-IVD marked for diagnostic use in EU and EEA countries (IVDR) and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas

Aiforia® Prostate Cancer HG-PIN

HGPIN 40x adv mask only-1

Supports the detection of high-grade prostatic intraepithelial neoplasia (high-grade PIN) in whole slide images (WSI) of prostate tissue. 


Aiforia® Prostate Cancer HG-PIN is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas. 

Hôpital Bicêtre AP-HP_logo
"We chose Aiforia’s AI algorithm because of its performance observed while testing on our whole slide images (WSI), because of the way the AI results are presented, and because Aiforia's prostate algorithm allows the pathologist to correct AI analysis with immediate implementation of the corrections into the results. This is a significant step towards accelerating the adoption of artificial intelligence in digital pathology, as it will speed up repetitive tasks in pathology workflows while improving the accuracy and consistency of image analyses."
Professor Catherine Guettier MD, PhD Former Head of Pathological Anatomy and Cytology Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP)
Find out more

Why Aiforia® Clinical Suites?

ic_define_pink

Tailored for the complexity of prostate cancer

From detailed Gleason pattern recognition to adverse feature detection, Aiforia’s prostate-specific tools are built to address the diagnostic challenges unique to prostate pathology. The suite enhances consistency and clarity in interpretation, supporting pathologists in delivering high-quality results across a range of prostate cancer cases.

Products_Clinical

Precise, transparent results

Aiforia takes accuracy beyond standard AI heatmaps by clearly marking the exact tumor areas with detailed visual overlays directly on the digital slides, enabling easy visual confirmation at any magnification level. This approach empowers pathologists with both visual transparency and exact quantitative data, such as accurate tumor area measurements and cell counts, delivering actionable insights.

Industry_CRO

Comprehensive case-level review and reporting

Aiforia® Clinical Suites conveniently combine results from multiple AI models, WSIs, and stainings into a case-level view and report for first-read diagnostic support.

ic_speed_up_pink

Speeds up each step in your workflow

The AI results are populated directly into the reporting panel. The user can utilize advanced features like case list triaging, pre-ordering of extra stains, and flagging of non-representative samples for a faster workflow.

Case studies, expert opinions, and more

Resources for prostate cancer pathology

Clinical_prostate_carousel-header

BLOG POST

AI enhances detection of high-risk prostate cancer features

Aiforia’s CE-IVD marked prostate cancer AI models enhance the speed and accuracy of diagnostic pathology workflows, guiding better treatment decisions.

Read more >

case-study-ai-assisted-prostate-cancer-diagnosis-blog-carousel

CASE STUDY

Case study: AI-assisted prostate cancer diagnosis

AI-assisted diagnosis was compared to visual diagnosis in a study involving H&E slides from 111 prostate cancer patients. Read about the results.

Read more >

5 reasons to use AI in clinical diagnostics

BLOG POST

5 reasons to use AI in clinical diagnostics

What benefits does AI bring to the digitized pathology workflow in clinical diagnostics? Read our article to find out.

Read more >

How did the Mayo Clinic choose a vendor for AI in pathology

BLOG POST

How did the Mayo Clinic choose a vendor for AI in pathology?

What to consider when choosing a vendor for AI in pathology? Learn how the Mayo Clinic evaluated platform providers based on six key criteria.

Read more >

prostate_grading_after_blog_carousel

BLOG POST

Benefits of AI and digital pathology to the clinical lab

Clinical pathologists, Dr. Kevin Sandeman and Dr. Tuomas Mirtti, discuss about the impact and benefits of AI and digital pathology in clinical diagnostics.

Read the case >

 

Contact us

Discover the power of AI for image analysis

Contact us to learn more about how Aiforia’s AI can enhance your diagnostic process and tailor it to your lab’s unique needs.

We will help you understand: 

  • How AI-assisted image analysis can increase efficiency, precision, and consistency in the pathology workflow.
  • The limitless possibilities Aiforia® Platform offers and the suitable solutions for your needs. 

Fill in the form, and one of our experts will contact you shortly.